Bulletin
Investor Alert

New York Markets Close in:

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

Market open

 --Real time quotes

Nov 28, 2022, 12:53 p.m.

/zigman2/quotes/201531540/composite

$

293.27

Change

-11.88 -3.89%

Volume

Volume 1.15m

Real time quotes

/zigman2/quotes/201531540/composite

Previous close

$ 305.15

$ 293.27

Change

-11.88 -3.89%

Day low

Day high

$290.35

$303.11

Open

52 week low

52 week high

$187.16

$307.53

Open

Annual Financials for Biogen Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 10.99B12.05B12.71B12.36B10.4B
Cost of Goods Sold (COGS) incl. D&A 2.09B2.2B2.42B2.26B2.6B
COGS excluding D&A 1.36B1.55B1.96B1.81B2.11B
Depreciation & Amortization Expense 721.6M650.6M464.6M457M487.3M
Depreciation 266.3M269.4M190.6M201.9M235.3M
Amortization of Intangibles 455.3M381.2M274M255.1M252M
Gross Income 8.9B9.86B10.29B10.09B7.81B
20172018201920202021 5-year trend
SG&A Expense 4.17B4.69B4.46B6.29B4.94B
Research & Development 2.25B2.6B2.09B3.79B2.27B
Other SG&A 1.92B2.1B2.37B2.5B-
Other Operating Expense -----
Unusual Expense 553.5M476.4M143.8M175.3M648.3M
EBIT after Unusual Expense (553.5M)4.69B5.69B3.63B2.22B
Non Operating Income/Expense (90.4M)54.6M207M759M(869.6M)
Non-Operating Interest Income 78.5M112.5M120M42M11M
Equity in Affiliates (Pretax) 1.2B1.25B1.3B847.3M640.5M
Interest Expense 245.6M200.6M187.4M225.8M253.6M
Gross Interest Expense 276.3M254.6M256.2M291M289.9M
Interest Capitalized 30.7M54M68.8M65.2M36.3M
Pretax Income 5.13B5.9B7.13B5.05B1.75B
Income Tax 2.46B1.43B1.16B992.3M52.5M
Income Tax - Current Domestic 2.26B1.18B1.01B688.2M342.2M
Income Tax - Current Foreign 108.6M140M84.4M155.1M137.1M
Income Tax - Deferred Domestic 250.9M(69.4M)1.14B(1.76B)(254.4M)
Income Tax - Deferred Foreign (159.2M)177.7M(1.07B)1.91B(172.4M)
Income Tax Credits -----
Equity in Affiliates --(79.4M)5.3M34.9M
Other After Tax Income (Expense) -----
Consolidated Net Income 2.67B4.47B5.89B4.06B1.73B
Minority Interest Expense 131M43.3M-59.9M171.5M
Net Income 2.54B4.43B5.89B4B1.56B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 2.54B4.43B5.89B4B1.56B
Preferred Dividends -----
Net Income Available to Common 2.54B4.43B5.89B4B1.56B
EPS (Basic) 11.9421.6231.4724.8610.44
Basic Shares Outstanding 212.6M204.9M187.1M160.9M149.1M
EPS (Diluted) 11.9221.5831.4224.8010.40
Diluted Shares Outstanding 213M205.3M187.4M161.3M149.6M
EBITDA 5.46B5.81B6.29B4.26B3.35B
Link to MarketWatch's Slice.